首页> 外文期刊>Seminars in pediatric surgery >Mechanisms of gut barrier failure in the pathogenesis of necrotizing enterocolitis: Toll-like receptors throw the switch
【24h】

Mechanisms of gut barrier failure in the pathogenesis of necrotizing enterocolitis: Toll-like receptors throw the switch

机译:坏死性小肠结肠炎发病机理中的肠屏障功能衰竭机制:Toll样受体引发了这一转变

获取原文
获取原文并翻译 | 示例
           

摘要

Necrotizing enterocolitis (NEC) is the leading cause of death from gastrointestinal causes in premature infants, and its overall survival has not improved in the past three decades. While the precise cause of NEC remains incompletely understood, we and others have shown that a major predisposing factor in the development and propagation of NEC is a breakdown of the intestinal barrier which leads to bacterial translocation and systemic sepsis. In seeking to identify the causes involved, we and others have also determined that activation of the receptor for bacterial endotoxin, namely toll-like receptor 4 (TLR4), is required for the development of intestinal barrier failure leading to NEC. We have also shown that the premature infant is endowed with strategies that can either limit or promote the extent of TLR4 signaling within the gut, which together determine the relative propensity with which NEC develops. In this review, we highlight the evidence for TLR4 signaling in the pathogenesis of NEC through a survey of its effects on gut barrier failure. We identify how TLR4 regulation within the gut can explain the unique susceptibility of the premature infant to the development of NEC, and highlight how strategies to limit the degree of TLR4 signaling can serve as novel therapeutic approaches for this devastating disease.
机译:坏死性小肠结肠炎(NEC)是早产儿胃肠道原因导致的死亡的主要原因,在过去的三十年中,其总生存率并未得到改善。虽然NEC的确切原因尚不完全清楚,但我们和其他人已经表明,NEC的发展和传播的主要诱因是肠屏障的破坏,这会导致细菌易位和系统性败血症。在寻找相关原因的过程中,我们和其他人也确定细菌内毒素受体(即Toll样受体4(TLR4))的激活是导致NEC的肠屏障衰竭发展所必需的。我们还表明,早产儿被赋予了可以限制或促进肠道内TLR4信号传导程度的策略,这些策略共同决定了NEC发展的相对倾向。在这篇综述中,我们通过对NEC对肠道屏障衰竭的影响进行调查,突出了TLR4信号在NEC发病机理中的证据。我们确定肠道内的TLR4调控如何解释早产儿对NEC发育的独特易感性,并强调限制TLR4信号传导程度的策略如何可以作为这种破坏性疾病的新颖治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号